Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-07T01:22:58.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an error screen. This indicates access is blocked and the study information cannot be viewed.
    Difference
    16%
    Check dated 2026-09-23T01:15:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing the previous Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-16T00:17:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.6.6', replacing the previous 'Revision: v3.6.5'. This appears to be a front-end/versioning update and does not change the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-01T20:00:36.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5. This indicates a newer version of the page, likely reflecting a minor update rather than substantive changes to study details.
    Difference
    0.1%
    Check dated 2026-08-11T19:47:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.